by Mybiogate | Oct 26, 2020 | Industry Research
Author: HE Sheng Masitinib and other indications enter clinical research Masitinib mesylate was developed by AB Science. Its clinical indications include amyotrophic lateral sclerosis (ALS), Alzheimer’s (AD), mastocytosis, pancreatic cancer, multiple sclerosis,... by Mybiogate | Oct 23, 2020 | Industry Research
Author: HE Sheng Age-related macular degeneration (AMD) is a serious and irreversible cause of visual impairment. It is also a leading cause of blindness among the elderly. As populations in China and around the world age, it is estimated that the number of... by Mybiogate | Oct 22, 2020 | Industry Research
Author: HE Sheng Parkinson’s disease is the second most common neurodegenerative disease after Alzheimer’s disease. It is caused by low levels of dopamine in the patient’s brain. As the disease progresses, the production of dopamine... by Mybiogate | Oct 21, 2020 | Industry Research
Author:MJ Yuan Editor:Ginger The history of human existence and development has also been a history of struggle against viruses. With recent outbreaks of SARS in 2003, MERS in 2012, or the current novel coronavirus in 2020, again and again there is an... by Mybiogate | Oct 20, 2020 | Industry Research
Author: Youwen Dai At the moment when venture capital funds are active in the field of biomedicine, oncology drug research and development companies have sprung up, but the CNS sector has received relatively little attention. The pace of life of contemporary... by Mybiogate | Oct 1, 2020 | Industry Research
Author: Chen Chun Editor: Youwen Dai COPD is the third-highest cause of mortality When discussions come up of lung cancer and its dangers and fears of new coronary pneumonia, the most common respiratory disease is sometimes ignored, COPD (chronic obstructive...